Lombard Odier Asset Management (USA) Corp
Source: SEC Form 13F · as of Mar 2026Lombard Odier Asset Management (USA) Corp holds 17 biotech & pharma companies tracked by BioSniper, totaling $138.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$138.0M
| Company | Shares | Value |
|---|---|---|
| BMYBRISTOL MYERS SQUIBB CO | 575,000 | $34.9M |
| GILDGILEAD SCIENCES, INC. | 231,958 | $32.3M |
| MRKMerck & Co., Inc. | 185,000 | $22.3M |
| PFEPFIZER INC | 660,000 | $18.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 40,000 | $10.8M |
| HLFHerbalife Ltd. | 402,500 | $5.9M |
| BHCBausch Health Companies Inc. | 666,000 | $3.6M |
| OGNOrganon & Co. | 570,000 | $3.4M |
| MCKMcKesson Corporation | 2,414 | $2.1M |
| CORCencora Inc. | 4,171 | $1.3M |
| GMOptec International, Inc. | 14,868 | $1.1M |
| ALKSAlkermes plc. | 10,232 | $362K |
| ICUIICU Medical Inc. | 2,504 | $323K |
| REGNREGENERON PHARMACEUTICALS, INC. | 395 | $305K |
| UTHRUNITED THERAPEUTICS Corp | 472 | $280K |
| DVADaVita Inc. | 1,758 | $270K |
| MEDPMedpace Holdings Inc. | 458 | $220K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.